Autolus Therapeutics Announces Pivotal Phase 2 FELIX Trial of…
LONDON, April 27, 2023 (GLOBE NEWSWIRE) — Autolus Therapeutics plc AUTHa clinical-stage biopharmaceutical company developing next-generation programmed T-cell therapies, today announced that the summary of